Cancer Immunotherapy: The Way to Nobel Prize in Medicine

Cancer Immunotherapy: The Way to Nobel Prize in Medicine

Rayzan E^{1, 2} ; Rezaei N^{1, 3, 4}

Show Affiliations

1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2. International Hematology/Oncology of Pediatrics Experts (IHOPE), Universal Scientific Education and Research Network (USERN), Tehran, Iran
3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Acta Medica Iranica Published:2018

[No abstract available]

Related Docs

Style	Citing Format
MLA	Rayzan E, Rezaei N. "Cancer Immunotherapy: The Way to Nobel Prize in Medicine." Acta Medica Iranica, vol. 56, no. 10, 2018, pp. 623-624.
APA	Rayzan E, Rezaei N (2018). Cancer Immunotherapy: The Way to Nobel Prize in Medicine. Acta Medica Iranica, 56(10), 623-624.
Chicago	Rayzan E, Rezaei N. "Cancer Immunotherapy: The Way to Nobel Prize in Medicine." Acta Medica Iranica 56, no. 10 (2018): 623-624.
Harvard	Rayzan E, Rezaei N (2018) 'Cancer Immunotherapy: The Way to Nobel Prize in Medicine', Acta Medica Iranica, 56(10), pp. 623-624.
Vancouver	Rayzan E, Rezaei N. Cancer Immunotherapy: The Way to Nobel Prize in Medicine. Acta Medica Iranica. 2018;56(10):623-624.
BibTex	@article{ author = {Rayzan E and Rezaei N}, title = {Cancer Immunotherapy: The Way to Nobel Prize in Medicine}, journal = {Acta Medica Iranica}, volume = {56}, number = {10}, pages = {623-624}, year = {2018} }
RIS	TY - JOUR AU - Rayzan E AU - Rezaei N TI - Cancer Immunotherapy: The Way to Nobel Prize in Medicine JO - Acta Medica Iranica VL - 56 IS - 10 SP - 623 EP - 624 PY - 2018 ER -